Weekly FDA Drug Pipeline Calendar (Nov 7 - Nov 11)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and rare blood types.
U.S. faces highest flu hospitalization rate in a decade with young kids and seniors most at risk
The U.S. is facing the highest flu hospitalization rates in more than a decade with children and the elderly most at risk, according to the Centers for Disease Control and Prevention.
J&J Making Bets On Heart Pump Maker Abiomed To Lift Sales
$Abiomed(ABMD.US$ shares traded higher this week after $Johnson & Johnson(JNJ.US$ announced that it will acquire the company for an upfront payment of $380 per share in an all cash transaction. The total value of the deal is $16.6 billion. Shares closed the week up 46% at $373.99.
Source: CNBC, BioPharmCatalyst, Benzinga
$Akero Therapeutics(AKRO.US$ $Milestone Pharmaceuticals(MIST.US$ $Mirum Pharmaceuticals(MIRM.US$ $Arrowhead Pharmaceuticals(ARWR.US$
$Akero Therapeutics(AKRO.US$ $Milestone Pharmaceuticals(MIST.US$ $Mirum Pharmaceuticals(MIRM.US$ $Arrowhead Pharmaceuticals(ARWR.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
913Followers
8Following
1472Visitors
Follow